Ticagrelor (Brilinta) 90 mg 180 tab

Product Description:
Brilinta (Ticagrelor) 90 mg by AstraZeneca is an advanced antiplatelet medication designed to reduce the risk of heart attack, stroke, and other cardiovascular events in patients with acute coronary syndrome (ACS) or a history of myocardial infarction. It helps prevent the formation of blood clots by inhibiting platelet aggregation, ensuring smoother blood flow through the arteries.

Key Features:

• Active Ingredient: Ticagrelor 90 mg
• Form: Film-coated tablets

Indications:

• Acute Coronary Syndrome (ACS)
• Prevention of recurrent myocardial infarction
• Secondary prevention of cardiovascular death or stroke

Dosage & Administration:
Typically, the recommended dose is 90 mg twice daily, taken orally with or without food, as directed by a healthcare professional.

Mechanism of Action:
Ticagrelor works by selectively inhibiting the P2Y₁₂ receptor on platelets, preventing their activation and aggregation. This reduces the likelihood of clot formation, helping protect against further heart-related complications.